Full Text
The Full Text of this article is available as a PDF (39.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Altman R., Brandt K., Hochberg M., Moskowitz R., Bellamy N., Bloch D. A., Buckwalter J., Dougados M., Ehrlich G., Lequesne M. Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. Osteoarthritis Cartilage. 1996 Dec;4(4):217–243. doi: 10.1016/s1063-4584(05)80101-3. [DOI] [PubMed] [Google Scholar]
- Bassleer C. T., Combal J. P., Bougaret S., Malaise M. Effects of chondroitin sulfate and interleukin-1 beta on human articular chondrocytes cultivated in clusters. Osteoarthritis Cartilage. 1998 May;6(3):196–204. doi: 10.1053/joca.1998.0112. [DOI] [PubMed] [Google Scholar]
- Bassleer C., Rovati L., Franchimont P. Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro. Osteoarthritis Cartilage. 1998 Nov;6(6):427–434. doi: 10.1053/joca.1998.0146. [DOI] [PubMed] [Google Scholar]
- Chalmers T. C., Smith H., Jr, Blackburn B., Silverman B., Schroeder B., Reitman D., Ambroz A. A method for assessing the quality of a randomized control trial. Control Clin Trials. 1981 May;2(1):31–49. doi: 10.1016/0197-2456(81)90056-8. [DOI] [PubMed] [Google Scholar]
- Felson D. T. Osteoarthritis. Rheum Dis Clin North Am. 1990 Aug;16(3):499–512. [PubMed] [Google Scholar]
- Guccione A. A., Felson D. T., Anderson J. J., Anthony J. M., Zhang Y., Wilson P. W., Kelly-Hayes M., Wolf P. A., Kreger B. E., Kannel W. B. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health. 1994 Mar;84(3):351–358. doi: 10.2105/ajph.84.3.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kramer J. S., Yelin E. H., Epstein W. V. Social and economic impacts of four musculoskeletal conditions. A study using national community-based data. Arthritis Rheum. 1983 Jul;26(7):901–907. doi: 10.1002/art.1780260712. [DOI] [PubMed] [Google Scholar]
- Oxman A. D., Cook D. J., Guyatt G. H. Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. JAMA. 1994 Nov 2;272(17):1367–1371. doi: 10.1001/jama.272.17.1367. [DOI] [PubMed] [Google Scholar]
- Rochon P. A., Gurwitz J. H., Cheung C. M., Hayes J. A., Chalmers T. C. Evaluating the quality of articles published in journal supplements compared with the quality of those published in the parent journal. JAMA. 1994 Jul 13;272(2):108–113. [PubMed] [Google Scholar]
- Ronca F., Palmieri L., Panicucci P., Ronca G. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage. 1998 May;6 (Suppl A):14–21. doi: 10.1016/s1063-4584(98)80006-x. [DOI] [PubMed] [Google Scholar]
- Setnikar I., Cereda R., Pacini M. A., Revel L. Antireactive properties of glucosamine sulfate. Arzneimittelforschung. 1991 Feb;41(2):157–161. [PubMed] [Google Scholar]
- Verbruggen G., Goemaere S., Veys E. M. Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA. Osteoarthritis Cartilage. 1998 May;6 (Suppl A):37–38. doi: 10.1016/s1063-4584(98)80010-1. [DOI] [PubMed] [Google Scholar]